你即將離開本站

並前往https://www.valueinhealthjournal.com/article/S1098-3015(16)01246-8/pdf

A228 - Value in Health

to golimumab treatment in RA/AS/PsA groups were 59/49/44 and 6.8/4.8/8.0 years, respectively. Golimumab was the first biologic in 79%/67%/70% of patients ...

確定！ 回上一頁

查詢 「Golimumab」的人也找了：

  1. golimumab仿單
    2.
  2. golimumab中文
    3.
  3. infliximab仿單
    4.
  4. simponi藥廠
    5.
  5. 欣普尼副作用
    6.
  6. 欣普尼自費價格
    7.
  7. Golimumab TNF-
    8.
  8. 欣普尼疫苗
    9.